CLINICAL TRIALS PROFILE FOR AMELUZ
✉ Email this page to a colleague
All Clinical Trials for AMELUZ
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01893203 ↗ | Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL) | Completed | Joint Authority for Päijät-Häme Social and Health Care | Phase 4 | 2013-08-01 | The aim of the study is to compare the efficacy of two photosensitizers, methyl-aminolaevulinate (MAL) and 5-aminolaevulinic nanoemulsion (BF-200 ALA) in the treatment of facial actinic keratosis. We use randomized, double-blinded prospective study design. The efficacy will be assessed clinically, histopathologically and immunohistochemically. |
| NCT01966120 ↗ | Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT) | Completed | Biofrontera Bioscience GmbH | Phase 3 | 2013-10-01 | The purpose of this study is to evaluate the safety and efficacy of BF-200 ALA (Ameluz) versus placebo in the field-directed treatment of mild to moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED lamp. |
| NCT02144077 ↗ | Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy | Completed | Accovion GmbH | Phase 3 | 2014-01-28 | The aim of this study is to test the effectiveness and safety of the medicine Ameluz® (5-aminolevulinic acid) in comparison to methyl-aminolevulinate (MAL), used with photodynamic therapy (PDT), to treat thin, non-aggressive BCC (basal cell carcinoma). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AMELUZ
Condition Name
Clinical Trial Locations for AMELUZ
Trials by Country
Clinical Trial Progress for AMELUZ
Clinical Trial Phase
Clinical Trial Sponsors for AMELUZ
Sponsor Name
